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The solution conformation of bovine anaphylatoxin C5a has been investigated by nuclear magnetic resonance (NMR) 
spectroscopy. The ‘H-NMR spectrum is assigned in a sequential manner using a variety of two-dimensional NMR tech- 
niques. A qualitative interpretation of the short range nuclear Overhauser enhancement data involving the NH, CaH 
and C%l protons suggests that CSa has four helices comprising residues 5-l 1, 15-25, 33-39 and 4661, and is composed 
of a globular head (residues 5-61) and a C-terminal tail. The polypeptide fold was determined by hybrid distance geo- 
metry-dynamical simulated annealing calculations on the basis of 203 approximate interproton distance restraints, 22 
distance restraints for 11 intrahelical hydrogen bonds (identified on the basis of the pattern of short range NOES and 
slowly exchanging backbone amide protons) and restraints for the 3 disulfide bridges. The overall polypeptide fold is 
similar to that of the sequence related human recombinant anaphylatoxin C5a [( 1988) Proteins 3, 139-1451. 
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1. INTRODUCTION 
The anaphylatoxin C5a is a small protein of 74 
residues which is released during the activation of 
the complement system by the action of a specific 
convertase on the parent complement protein CS 
[l]. Like the two related anaphylatoxins C3a and 
C4a, C5a plays an important role in the inflam- 
matory process inducing multiple cellular effects, 
and may also be involved in the pathogenesis of a 
number of inflammatory diseases [l]. The amino 
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acid sequences of C5a from a variety of species 
have been determined [2-51 and circular dichroism 
studies have suggested a helical content of 40-50% 
[1,5]. Very recently, the solution structure of 
human recombinant C5a has been investigated by 
NMR [6,7] and shown to be similar to that of the 
crystal structure of C3a [8]. The structures dif- 
fered, however, at the N-terminus which was 
helical in solution but disordered in the crystal. In 
the present paper we have examined the solution 
conformation of bovine C5a by NMR. The se- 
quence homology between the bovine and human 
forms of C5a is 68% [5]. We show that the secon- 
dary structure and overall polypeptide fold are 
similar to that of human recombinant CSa. 
2. EXPERIMENTAL 
2.1. Purification and biological activity of bovine C5a 
C5a was purified from 48 litres of yeast activated bovine 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 289 
Volume 238, number 2 FEBS LETTERS October 1988 
serum (-3.9 kg protein). The initial purification steps up to the 
ammonium sulfate precipitation steps were as described in [5]. 
After dialysis, the precipitate (42 g of protein) was loaded in 12 
batches on an immunoaffinity column (60 ml), prepared by 
coupling the total protein A-purified IgG fraction of rabbit 
antiC5a serum [5] to Affi-Gel 10 (Bio-Rad). After extensive 
washing with 10 mM sodium phosphate (pH 7.4)IO.S M 
NaCl/O.l% NP-40, the protein bound to the affinity column 
was eluted with 0.1% trifluoroacetic acid (total yield 177 mg). 
This was followed by reverse-phase chromatography through a 
PepRPC HR lO/lO column (Pharmacia) eluted with a O-100% 
gradient of acetonitrile in 0.1% trifluoroacetic acid. This 
purification procedure yielded 58 mg of C5a, which was 
homogeneous as shown by SDS and urea polyacrylamide gel 
electrophoresis. This represents a recovery of 40-45% of CSa, 
as calculated from the molecular mass and serum concentration 
of the fifth complement component. The purified C5a exhibited 
maximal stimulation of neutrophil chemotaxis and superoxide 
production at concentrations of lo-’ and lo-’ M, respectively 
191. 
2.2. NMR spectroscopy 
All NMR spectra were recorded on a Bruker AM-500 spec- 
trometer. The samples for NMR contained 6 mM C5a in either 
90% H*O/lO% D20 or 99.996% D20, pH 4.6. All two- 
dimensional spectra were recorded in the pure-phase absorption 
mode using the time proportional incrementation method 
[lO,l I]. The following spectra were recorded both in Hz0 and 
DzO: NOESY [12] with mixing times of 100, 200 and 300 ms, 
and HOHAHA [13,14] with mixing times ranging from 20 to 
60 ms. For measurements in HzO, the water resonance was sup- 
pressed by replacing the last 90” pulse in the NOESY sequence 
by a semi-selective jump-return (90;~r-90!,) pulse [IS] and by 
adding the sequence 90:-H-3-90;-r-90!, after the MLEVl7, 
sequence in the case of the HOHAHA sequence [16] (where H 
is a homospoil pulse of 3 ms, A a 3 ms delay to allow for 
recovery from the homospoil, and 7 a 80,~s delay). 
2.3. Calculations 
Structure calculations on the basis of NOE derived inter- 
proton distance data were carried out using the hybrid distance 
geometry-dynamical simulated annealing approach 1171, which 
makes use of the programs DISGEO [18] and XPLOR [19,20]. 
Computations were carried out on a CONVEX Cl-XP 
computer. 
3. RESULTS AND DISCUSSION 
The ‘H-NMR spectrum of C5a was assigned in 
a sequential manner [21] using HOHAHA spectra 
recorded at several mixing times ranging from 20 
to 60 ms to demonstrate direct, single and relayed 
through-bond connectivities and NOESY spectra 
to delineate through-space (< 5 A) connectivities. 
The most useful NOES in this respect involve the 
NH, CH and CBH protons and are of the type 
NH(i)-NH(i + l), C”H(i)/CflH(i)-NH@+ l), 
CW(+NH(i + 3)/C@H(i + 3). In order to resolve 
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ambiguities arising from cross-peak overlaps, we 
found it essential to record spectra at several 
temperatures, in particular 15”C, 25°C and 35°C. 
Examples of NOESY spectra in Hz0 displaying the 
NH-NH and NH-C”H/@H region of the spec- 
trum are shown in fig. 1. Sequential connectivities 
extended from residue 5 to residue 66. No sequen- 
tial NOES could be detected for the first 4 N- 
terminal residues and the 8 C-terminal residues, 
presumably due to a higher degree of mobility. 
A summary of NOES between residues less than 
five apart in the sequence involving the NH, C”H 
and C@H protons is shown in fig.2. The secondary 
structure of C5a can be deduced on the basis of a 
qualitative interpretation of this data [21,22]. In 
particular, the stretches of NH(i)-NH(i+ 1) NOES 
together with the presence of C%(i)-NH(i+ 3,4) 
and VII(i)-C%(i+ 3) NOES and slowly exchang- 
ing backbone amide protons reveal the presence of 
four helices comprising residues 5-l 1, 15-25, 
33-39 and 46-61. This corresponds to a helical 
content of 55% which is consistent with the results 
from circular dichroism measurements [ 1,5]. 
To obtain the approximate polypeptide fold, a 
set of 203 interproton distance restraints, compris- 
ing 134 sequential ( I i - j I = l), 44 medium range 
(1 < Ii-jl I 5) and 25 long range (Ii--j1 > 5) 
distances were derived from the NOESY spectra 
recorded with mixing times of 100 ms and 200 ms 
at 15°C 25°C and 35°C. These were classified into 
three distance ranges, 1.8-2.7 A, 1.8-3.3 A and 
1.8-5.0 A, corresponding to strong, medium and 
weak NOES, respectively [23,24]. The upper limits 
of distances involving methyl and methylene pro- 
tons were corrected for centre (rc) averaging 
(which is equivalent o the use of pseudo-atoms) as 
described in [25]. The interproton distance 
restraints were supplemented by two additional 
sets of distance restraints: (i) 22 restraints for the 
11 intrahelical NH(i + 4)-O(i) hydrogen bonds 
identified on the basis of slowly exchanging amide 
protons and the presence of C”H(+NH(i+3,4) 
and/or C%(r)-C@H(i+ 3) NOES [26] (for each 
hydrogen bond the N(i + 4)-O(i) and NH(i + 4)-O(i) 
distances were constrained to ~3.3 A and <2.3 A, 
respectively); and restraints for the three disulfide 
bonds between Cys-21 and Cys-47, Cys-22 and 
Cys-54, and Cys-34 and Cys-55 [8,27]. In addition, 
weak restraints in the form of square-well poten- 
tials [24] were imposed on selected 4 and $ 
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Fig.1. (A) NH(F1 axis)-NH(F2 axis) and (B) NH(F2)-CW/C’H (FI axis) regions of the 200 ms NOESY spectrum of CSa in 90% 
HzO/lO% DzO at 35°C. In (A) stretches of NH(i)-NH(i+ 1) connectivities for helices 1 and 4 are indicated by dashed (---) and 
continuous (-_) lines, respectively, with the labelling of the cross-peaks at the Fl frequency of the corresponding NH proton. In 
(B), some C%(r)-NH(i+ 1) and C%(I)-NH(i+ 3) NOE connectivities are indicated by continuous (---) and dashed (---) lines, 
respectively. Also indicated in (B) are a few C’H(r]-NH(i+ 1) connectivities. The labelling in (B) is at the C?-l(r)-NH(Q and C’H(i)- 
NH(r) intraresidues cross-peaks, the latter indicated by the residue number followed by the letter fl. 
backbone torsion angles as follows. First all 4 
backbone torsion angles outside the helical 
regions, with the exception of those for the Gly 
and Asn residues, were restrained between - IO” 
and - 180” on the basis of a survey of high resolu- 
tion X-ray structures in the Brookhaven protein 
data bank. (Note that the probability for 4 values 
outside this range is ~2%; [28].) Second, within 
the helical regions, the 4 and $ angles of residues 
5-l 1, 17-24, 33-39 and 47-60 were restrained to 
the ranges listed in table 1 using the method of 
Sherman et al. [28] to determine the most probable 
values of the d,# angles for a given set of observed 
NH(+NH(i + I), C%(z)-NH(i + 1) and @H(i)- 
NH(I’+ 1) NOES. The introduction of these @,$ 
restraints has no effect on the determination of the 
overall polypeptide fold but helps circumvent pro- 
blems associated with local mirror images. 
Five structures which satisfied the experimental 
restraints, displayed very small deviations from 
idealized covalent geometry, and had good non- 
bonded contacts, were computed using the hybrid 
distance geometry-dynamical simulated annealing 
approach described in [17]. The orientation of the 
four helices with respect to each other was well 
defined by the data. The details of the local 
backbone structure as well as the side chain con- 
formations could not be determined on the basis of 
the present data. This will require further ex- 
perimental work to obtain a much larger number 
of interproton distance restraints as well as 
stereospecific assignments of the ,&methylene pro- 
tons. Consequently, only a schematic representa- 
tion of the polypeptide fold is shown in fig.3. 
The structure is dominated by a globular head 
(residues 5-61) and a tail (residues 62-74). The 
main stabilizing factors within the globular head 
are the disulfide bridges between helices 2 and 3 on 
the one hand and helix 4 on the other, sup- 
plemented by a number of hydrophobic interac- 
tions. In this respect we note that of the 7 aromatic 
residues, only two, Tyr 13 and Phe 5 1, are partially 
buried within the globular core. This is consistent 
with the observation that, of the two tyrosine 
residues present in CSa, only Tyr 23 is susceptible 
to chemical modification [29]. Helices 1 and 3 are 
approximately antiparallel to helix 4, while helix 2 
is at an angle of -70” to helix 4. The orientation 
of helix 1 with respect o helix 4 is determined by 
NOES from Tyr-13 to Ala-50, Phe-51 and Ser-53, 
and from Ile-6 to Ala-58. 
The polypeptide fold of bovine C5a is similar to 
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Fig.2. Summary of NOES involving the NH, C”H and CBH protons of residues less than five apart in the sequence observed for C5a 
together with the secondary structure derived from them. The closed circles indicate slowly exchanging (>24 h) backbone amide 
protons. The C”H(IJ-@H(~+ 1) NOE between Gly-44 and Pro-45 is indicated by a hatched box along the same line as the C%(i)- 
NH(I’+ 1) NOES. 
that of both human recombinant C5a [7] and C3a 
[8]. There are a number of differences though be- 
tween the solution conformation of human and 
bovine C5a on the one hand and the crystal struc- 
ture of C3a on the other. Helix 4 extends way 
beyond the globular head in the crystal structure of 
C3a and is 10 residues longer than that of CSa. It 
appears that this helix is stabilized by packing in- 
teractions since C3a is a dimer in the crystal with 
the interface formed by the C-terminal helices ar- 
ranged in an anti-parallel manner [8]. The first 12 
Table 1 
q5 and 4 restraints used within the helical regions derived on the 
basis of the pattern of observed NH(+NH(i+ l), C”H(r)- 
NH(i+ 1) and @H(i)-NH(i+ 1) NOEsa 
Class NOES ti (“) + (“) 
NH(r)- CBH(i)- C”H(i)- 
NH(i+ 1) NH(i+ 1) NH(i+ 1) 
Q + -85 * 60 -5+ 60 
QR + 
Or + + -70 + 70 -20 + 90 
R + + -65*60 -35t 90 
K + + + -75+60 -1Ot 60 
TK + + 
Or + + + -83 + 80 5 + 130 
a The classes Q, R, T and K are those of Sherman et al. [18]. 
The classes QR and TK are combined classes where the 
absence or presence of a particular NOE cannot be assessed 
due to spectral overlap. The values of the ranges of classes Q, 
R and K are approximately three times. the values of the 
standard deviations from the most probable 4 or $ value 
given by Sherman et al. [28] 
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residues of C3a were not visible in the electron den- 
sity map, while in the case of CSa there is a N- 
terminal helix (residues 5-l 1). The location of this 
helix with respect to the rest of the protein is in 
agreement with the prediction of Greer based on 
model building studies [30]. Interestingly, 
although the polypeptide fold of C3a in solution 
has not yet been determined, its secondary struc- 
ture is almost identical to that of C5a, particularly 
with regard to the presence of helix 1 and the 
length of helix 4 [31]. It would thus appear that the 
solution structures of the 
display the same differences 
crystal structure of C3a. 
39 
Q 2. 33 5 
3 46 
anaphylatoxins all 
with respect to the 
Fig.3. Schematic representation of the polypeptide fold of CSa 
as derived from the NOE distance data and hybrid distance 
geometry-dynamical simulated annealing calculations. Helices 
are represented as cylinders and the other residues as thick lines. 
The disulfide bridges are indicated by straight lines. 
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Alignment of the primary sequences of C3a, C4a 
and C5a shows that, in addition to the six Cys 
residues, there is total conservation of the follow- 
ing residues [32]: Tyr-13(15), Gly-25(26), 
Arg-37(39), Phe-51(53) and Arg-62(64) (numbers 
in parentheses refer to C3a and C4a). Do these 
residues have a common role in the structures of 
C5a and C3a? Tyr-13 and Phe-51 are buried in C5a 
and are probably involved in the stabilization of 
the globular head. Phe-53 in C3a is likewise buried 
but Tyr-15 is exposed. This, however, is because 
the N-terminus is not folded in the crystal structure 
[8]. Gly-25 in C5a and Gly-26 in C3a both occur at 
the end of helices and may therefore act as helix 
breakers. Arg-37(39) is directed towards the in- 
terior and may be involved in stabilizing elec- 
trostatic interactions in both C5a and C3a. Arg-62 
is one residue removed from the C-terminus of 
helix 4 and may form part of the active site (see 
below). 
Despite the overall structural similarity, C5a and 
C3a display distinct differences with respect to 
structure-function relationships [l]. In the case of 
C3a, all biological actions are mimicked by the C- 
terminal synthetic octapeptide 70-77 [33]. In con- 
trast, analogous C-terminal synthetic peptides of 
C5a exhibit no activity [34]. While the C-terminal 
Arg-74 appears to be essential for spasmogenic ac- 
tivity, it is not required for chemotactic activity 
and lysosomal release which can still be induced by 
C5a desArg-74 [34]. Further, the C5a(l-69) frag- 
ment is sufficient for receptor interaction although 
it does not stimulate a cellular response [5,34]. At 
the same time, it appears that the N-terminus may 
also play a role in C5a activity as the CSa(18-74) 
fragment is active, albeit a factor of -1000 less 
than C5a desArg-74 [35]. This is supported by the 
close proximity of the C-terminal end of helix 4 
and the N-terminal end of helix 1. Tyr-23 which is 
located on the exposed surface of helix 2, also ap- 
pears to participate in ligand-receptor interactions 
[29]. Indeed, photoreactive derivatives of C5a, 
prepared by specifically modifying Tyr-23, fail to 
interact with the granulocyte C5a receptor, while 
retaining their binding to a specific anti-C5a 
monoclonal antibody [29]. This suggests that there 
are two areas on C5a involved in the interaction 
with the cellular C5a receptor(s). The first, like 
that of C3a, probably comprises the C-terminal 
tail, while the second may be made up of the con- 
tiguous polar surface formed by helices 1 and 2 
comprising Glu-7, Lys-20, Tyr-23 and His-27, 
possibly supplemented by Arg-62. 
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